课题基金 / 基金详情

Novel chmosensitivity testing using molecular dynamics responding to anticancer drugs

Novel chmosensitivity testing using molecular dynamics responding to anticancer drugs
利用对抗癌药物的分子动力学进行新型化学敏感性测试
批准号:
17591435
负责人:
KUBOTA Tetsuro
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

KUBOTA Tetsuro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Purpose : To evaluate whether changes in the expression of early-response genes (GADD153, p21, and c-Jun) can indicate chemotherapy response in gastric cancer.Experimental Design : Three human gastric cancer cell lines (TMK-1,MKN-45, and MKN-74) were exposed to 5-fluorouracil (5-FU) or cisplatin (CDDP) in vitro. Xenografts of TMK-1 in nude mice were also treated with 5-FU or CDDP in vivo. For each of these treatments, we tested for a correlation between early gene expression levels and inhibition ratios (IR) derived at a later time. Finally, S-1 and CDDP were administered to 12 patients with advanced gastric cancer for three weeks. Among patients in different response groups, expression levels of GADD153, p21, and c-Jun were compared using biopsy specimens that were obtained by endoscopy soon after initiation of chemotherapy.Results : There was a significant correlation between the expression levels of these genes at 24 hours (as measured by real-time PCR) and IRs at 72 hours in vitro … More (GADD153;r=0.89, P<0.001, p21;r=0.93, P<0.001, and c-Jun; r=0.80, P<0.001). Receiver-operating characteristic (ROC) curves revealed that the cut-off values (calculated to predict the effectiveness of chemotherapy) for GADD153, p21, and c-Jun were 1.3, 1.8, and 2.1, respectively. There was also a significant correlation between gene expression levels at 2 days and IRs at 21 days in vivo (GADD153;r = 0.77, P<0.001, p21;r = 0.85, P<0.001, and c-Jun ; r = 0.87, P<0.001). ROC curves defined the cut-off values as 1.8 for GADD153, 1.9 for p21, and 2.2 for c-Jun. In clinical Gene Expression and Response Prediction studies, levels of early-response gene expressions at 3-7 days in patients showing progressive disease (PD) were significant lower than those in patients with partial response (PR) (GADD153;P=0.002, P21;P = 0.003, and c-Jun ; P=0.033).Conclusions : These results suggest that changes in the expression of the three early response genes soon after drug administration could improve predictions of the final outcome of chemotherapy in gastric cancer. Less
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
抗癌剤感受性と遺伝子多型
抗癌药物敏感性与基因多态性
DOI: --
发表时间: 2005
期刊: Bitoherapy 19(6)
影响因子: --
作者: [久保田哲朗, 西山正彦, 吉野肇一, 久保田哲朗, 久保田哲朗, 久保田哲朗]
通讯作者: 久保田哲朗
Chemosensitivity and resistance testing : to be "standard" or to be individualized, that is the question.
化学敏感性和耐药性测试:是“标准”还是个体化,这是个问题。
DOI: --
发表时间: 2006
期刊: Gastric Cancer 9
影响因子: --
作者: [Kubota T, et al.]
通讯作者: et al.
Endoscopic classifications as diagnostic factors of peptic ulcer and early gastric cancer - a possible reason why Helicobacter pylori infection causes gastric ulcers along lesser curvature.
内镜分类作为消化性溃疡和早期胃癌的诊断因素——幽门螺杆菌感染导致胃小弯溃疡的可能原因。
DOI: --
发表时间: 2006
期刊: Aliment. Pharmacol. Ther. symp 2
影响因子: --
作者: [Yoshida, M., Kubota, T., et al.]
通讯作者: et al.
TSU-68 (SU6668) inhibits local tumor growth and liver metastasis of human colon cancer xenografts via anti-angiogenesis.
TSU-68 (SU6668) 通过抗血管生成抑制人结肠癌异种移植物的局部肿瘤生长和肝转移。
DOI: --
发表时间: 2005
期刊: Oncology Report 14
影响因子: --
作者: [Yozrozuya, K, Kubota T, et al.]
通讯作者: et al.
22
    Chemo-resistance-related genes detected by cDNA microarray
    • 批准号:
      14571225
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.56万
    • 财政年份:
      2002
    • 负责人:
      KUBOTA Tetsuro
    • 依托单位:
    New strategy in cancel therapy with reference tomethionine-depletion
    • 批准号:
      07671329
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.6万
    • 财政年份:
      1995
    • 负责人:
      KUBOTA Tetsuro
    • 依托单位:
    Cloning of suppressor gene of metastasis using subtraction hybridization method
    • 批准号:
      05671026
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      1993
    • 负责人:
      KUBOTA Tetsuro
    • 依托单位:
    Comparative study of concentrations of antitumor agents in serum and tumor in nude mouse and human
    • 批准号:
      62570579
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.54万
    • 财政年份:
      1987
    • 负责人:
      KUBOTA Tetsuro
    • 依托单位:
    国内基金
    海外基金
    Entpd5在上皮性卵巢癌对Cisplatin继发耐药中的分子作用机制研究
    • 批准号:
      81703078
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      黄莉萍
    • 依托单位:
    构建基于TRAIL-exosome的siRNA和Cisplatin共载纳米系统及治疗耐药宫颈癌的研究
    • 批准号:
      81671809
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2016
    • 负责人:
      朱雪琼
    • 依托单位:
    CUDC-101联合cisplatin对卵巢癌腹水细胞spheroid形成及转移机制的相关研究
    • 批准号:
      81402127
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      21.0万元
    • 批准年份:
      2014
    • 负责人:
      孟凡良
    • 依托单位:
    NSAIDs增强卵巢癌细胞对顺铂、紫杉醇药物敏感性的机理研究